Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Bing-Neel syndrome: Two unexpected cases and a review of the literature.

Van Cauwenberge MG, Depreter B, Dumoulin EN, Emmerechts J, Nollet F, Vanopdenbosch LJ.

J Neurol Sci. 2015 Jun 16. pii: S0022-510X(15)00367-6. doi: 10.1016/j.jns.2015.06.026. [Epub ahead of print] Review.

PMID:
26159625
2.

Multiple nocardial abscesses of the brainstem and spinal cord diagnosed after an open biopsy through a cervical partial central corpectomy: case report.

Peeters I, Casselman JW, Vandecasteele SJ, Janssen A, Regaert B, Vantomme N, Vanopdenbosch LJ.

J Neurosurg Spine. 2015 Jun 19:1-4. [Epub ahead of print]

PMID:
26091435
3.

Pseudotumoral rebound of multiple sclerosis in a pregnant patient after stopping natalizumab.

Verhaeghe A, Deryck OM, Vanopdenbosch LJ.

Mult Scler Relat Disord. 2014 Mar;3(2):279-81. doi: 10.1016/j.msard.2013.10.001. Epub 2013 Oct 3.

PMID:
25878019
4.

Are atraumatic spinal needles as efficient as traumatic needles for lumbar puncture?

Pelzer N, Vandersteene J, Bekooij TJ, Schoonman GG, Wirtz PW, Vanopdenbosch LJ, Koppen H.

Neurol Sci. 2014 Dec;35(12):1997-9. doi: 10.1007/s10072-014-1924-0. Epub 2014 Aug 20.

PMID:
25139108
5.

Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.

van Pesch V, Bartholomé E, Bissay V, Bouquiaux O, Bureau M, Caekebeke J, Debruyne J, Declercq I, Decoo D, Denayer P, De Smet E, D'hooghe M, Dubois B, Dupuis M, Sankari SE, Geens K, Guillaume D, van Landegem W, Lysandropoulos A, de Noordhout AM, Medaer R, Melin A, Peeters K, Ba RP, Retif C, Seeldrayers P, Symons A, Urbain E, Vanderdonckt P, Van Ingelghem E, Vanopdenbosch L, Vanroose E, Van Wijmeersch B, Willekens B, Willems C, Sindic C.

Acta Neurol Belg. 2014 Sep;114(3):167-78. doi: 10.1007/s13760-014-0308-9. Epub 2014 Jun 11.

PMID:
24915752
6.

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group.

Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23.

PMID:
24461574
7.

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.

Cambron M, Mostert J, Haentjens P, D'Hooghe M, Nagels G, Willekens B, Heersema D, Debruyne J, Van Hecke W, Algoed L, De Klippel N, Fosselle E, Laureys G, Merckx H, Van Wijmeersch B, Vanopdenbosch L, Verhagen W, Hupperts R, Hengstman G, Michiels V, Van Merhaegen-Wieleman A, De Keyser J.

Trials. 2014 Jan 25;15:37. doi: 10.1186/1745-6215-15-37.

8.

Anti-glycine receptor antibody mediated progressive encephalomyelitis with rigidity and myoclonus associated with breast cancer.

De Blauwe SN, Santens P, Vanopdenbosch LJ.

Case Rep Neurol Med. 2013;2013:589154. doi: 10.1155/2013/589154. Epub 2013 Jul 10.

9.

MRI characteristics of trigeminal nerve involvement in patients with multiple sclerosis.

Swinnen C, Lunskens S, Deryck O, Casselman J, Vanopdenbosch L.

Mult Scler Relat Disord. 2013 Jul;2(3):200-3. doi: 10.1016/j.msard.2012.12.002. Epub 2013 Jan 10.

PMID:
25877726
10.

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators.

N Engl J Med. 2012 Sep 20;367(12):1098-107. Erratum in: N Engl J Med. 2012 Dec 13;367(24):2362.

11.

Resolution of abnormal fractional anisotropy of substantia nigra in organophosphate intoxication.

Swinnen C, Vanacker P, Casselman J, Van Zandijcke M, Vanopdenbosch L.

Acta Neurol Belg. 2011 Dec;111(4):378. No abstract available.

PMID:
22368991
12.

Vascular aspects of multiple sclerosis.

D'haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J.

Lancet Neurol. 2011 Jul;10(7):657-66. doi: 10.1016/S1474-4422(11)70105-3. Review.

PMID:
21683931
13.

Toxocariasis presenting as encephalomyelitis.

Helsen G, Vandecasteele SJ, Vanopdenbosch LJ.

Case Rep Med. 2011;2011:503913. doi: 10.1155/2011/503913. Epub 2011 May 5.

14.

Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.

Verhelst X, Vanhooren G, Vanopdenbosch L, Casselman J, Laleman W, Pirenne J, Nevens F, Orlent H.

Transpl Int. 2011 Apr;24(4):e30-4. doi: 10.1111/j.1432-2277.2010.01190.x. Epub 2010 Dec 7. Review.

PMID:
21134241
15.

Art, medicine and surgery: puncture of ascites.

Van Hee R, Dequeker J, Vanopdenbosch L.

Acta Chir Belg. 2010 Jul-Aug;110(4):492-7. No abstract available.

PMID:
20919677
16.

MRI with intrathecal gadolinium to detect a CSF leak: a prospective open-label cohort study.

Vanopdenbosch LJ, Dedeken P, Casselman JW, Vlaminck SA.

J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):456-8. doi: 10.1136/jnnp.2009.180752. Epub 2010 Jun 20.

PMID:
20562454
17.

Post-traumatic pulsatile tinnitus: the hallmark of a direct carotico-cavernous fistula.

Lerut B, De Vuyst C, Ghekiere J, Vanopdenbosch L, Kuhweide R.

J Laryngol Otol. 2007 Nov;121(11):1103-7. Epub 2007 Feb 13.

PMID:
17295936
18.

Linezolid-induced inhibition of mitochondrial protein synthesis.

De Vriese AS, Coster RV, Smet J, Seneca S, Lovering A, Van Haute LL, Vanopdenbosch LJ, Martin JJ, Groote CC, Vandecasteele S, Boelaert JR.

Clin Infect Dis. 2006 Apr 15;42(8):1111-7. Epub 2006 Mar 13.

19.

The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis.

Régal L, Vanopdenbosch L, Tilkin P, Van den Bosch L, Thijs V, Sciot R, Robberecht W.

Arch Neurol. 2006 Feb;63(2):262-7. Erratum in: Arch Neurol. 2006 Jul;63(7):963.

PMID:
16476815
20.

Bell's palsy with ipsilateral numbness.

Vanopdenbosch LJ, Verhoeven K, Casselman JW.

J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):1017-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk